Evidence map›Paper›PMID 37664715›Full record

ArticleHeliyon2023

Improved survival of SARS COV-2-infected K18-

Barbara J Mann, Preeti Chhabra, Mingyang Ma, Savannah G Brovero, Riley T Hannan, Jeffrey M Sturek, Marieke K Jones, Joel Linden, Kenneth L Brayman

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Barbara J MannDepartment of Medicine, Division of Infectious Diseases, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Preeti ChhabraDepartment of Surgery, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Mingyang MaDepartment of Surgery, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Savannah G BroveroDepartment of Medicine, Division of Infectious Diseases, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Riley T HannanDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Jeffrey M SturekDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Marieke K JonesClaude Moore Health Sciences Library, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Joel LindenDepartment of Medicine, Division of Nephrology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Kenneth L BraymanDepartment of Surgery, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
University of Virginia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A life-threatening manifestation of Covid-19 infection is a cytokine storm that requires hospitalization and supplemental oxygen. Various strategies to reduce inflammatory cytokines have had some success in limiting cytokine storm and improving survival. Agonists of adenosine A

Indexed as

Adenosine agonistsApadenosonCOVID-19SARS CoV2Therapy

Identifiers

PMID37664715
PMCPMC10469936
OpenAlexW4385973343

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.